Find out what’s new

Using Artificial Intelligence to Semi-Quantitate Coronary Calcium as an ‘Incidentaloma’ on Non-Gated, Non-Contrast CT Scans, A Single-Center Descriptive Study in West Michigan.

Artificial Intelligence in Coronary Artery Calcium Scoring

Opportunistic screening with AI could be a game-changer for preventive cardiology

Non-Alcoholic Fatty Liver Disease, Heart Failure, and Long-Term Mortality: Insights From the National Health and Nutrition Examination Survey

To evaluate the association between non-alcoholic fatty liver disease (NAFLD), heart failure (HF), and all-cause mortality. Both NAFLD and HF are increasing in prevalence due to shared risk factors.

Use of AI opportunistic screening in CT for cardiovascular disease

“We’re finding that when you apply AI to these non-cardiac chest CTs, it’s possible to detect coronary calcifications in patients who may otherwise go unnoticed,” explained Ron Blankstein, MD

Nanox Highlighted on TIME’s Best Inventions of 2024 List for its AI Solutions

Nanox AI’s Solutions selected for Special Mention on annual list recognizing the most impactful new products and ideas

AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease

This new AASLD Guidance document reflects many advances in the field pertinent to any practitioner caring for patients with NAFLD and emphasizes advances in noninvasive risk stratification and therapeutics.

Detection of Moderate Hepatic Steatosis on Portal Venous Phase Contrast-Enhanced CT: Evaluation Using an Automated Artificial Intelligence Tool

Precontrast CT is an established means of evaluating for hepatic steatosis; postcontrast CT has historically been limited for this purpose.

A recent study suggests high clinical and economic efficacy for opportunistic screening using the AI tools. Nanox.AI solutions can enable and simplify cost savings by helping detect and report opportunistic findings related to chronic diseases

To assess the cost-effectiveness and clinical efficacy of AI-assisted abdominal CT-based opportunistic screening for atherosclerotic cardiovascular (CV) disease, osteoporosis, and sarcopenia using artificial intelligence (AI) body composition algorithms.

In the study population – NanoxAI Bone tool helped detect more patients at-risk of osteoporosis when comparing to standard of care (FRAX)

Methods for identifying patients at high risk for osteoporotic fractures, including dual-energy X-ray absorptiometry (DXA)1,2 and risk predictors like the Fracture Risk Assessment Tool (FRAX)3-6, are underutilized.

Vertebral fractures are often undiagnosed and missed by FLSs. We have demonstrated the impact of an AI-enabled vertebral fracture FLS pathway using existing CT images on anti-osteoporosis treatment adherence

One-year Anti-Osteoporosis Medication Use in Patients Identified by an AI-enabled Vertebral Fracture Pathway in the Fracture Liaison Service Setting

Automated opportunistic osteoporotic fracture risk assessment using computed tomography scans to aid in FRAX underutilization

Methods for identifying patients at high risk for osteoporotic fractures, including dual-energy X-ray absorptiometry (DXA)1,2 and risk predictors like the Fracture Risk Assessment Tool (FRAX)3,4,5,6, are underutilized. We assessed the feasibility of automatic, opportunistic fracture risk evaluation based on routine abdomen or chest computed tomography (CT) scans.